Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cerebellar Connectome.

Cerebellum (London, England)·2026
Same author

3for1 intervention program-short-term psychotherapy, job coaching, and peer support for unemployed individuals facing psychological distress: a community case study.

Frontiers in public health·2026
Same author

Quantitative Assessment of GFAP-Based Astrocyte Morphology in the Cuprizone Model: A Comparative Evaluation of Neurolucida<sup>®</sup> 360 and SNT.

Cells·2026
Same author

Astrocytic Accumulation at the Choroid Plexus Attachment Region.

Cellular and molecular neurobiology·2026
Same author

Evaluation of lactic acid as a novel fixative for histological and neuroanatomical applications.

Scientific reports·2026
Same author

Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes.

Acta neuropathologica·2026

Related Experiment Video

Updated: Jul 10, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Modeling and simulation for prediction of multiple sclerosis progression.

Vishnu Prathapan1, Peter Eipert1, Nicole Wigger2

  • 1Medical School Hamburg University of Applied Sciences and Medical University, Am Kaiserkai 1, 20457, Hamburg, Germany.

Computers in Biology and Medicine
|April 24, 2024
PubMed
Summary

This study proposes using computational models and connectomes to predict multiple sclerosis (MS) progression. The Hodgkin-Huxley model simulates changes in neuronal signaling, offering a new tool for understanding MS disease trajectories.

Keywords:
Computational modelDisease progressionMultiple sclerosisNetwork modelNeuronal patternsProgression prediction

More Related Videos

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.1K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.4K

Related Experiment Videos

Last Updated: Jul 10, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.1K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.4K

Area of Science:

  • Neuroscience
  • Computational Biology
  • Biomedical Engineering

Background:

  • Multiple sclerosis (MS) has numerous predictive techniques, including clinical, radiological, biological, and computational markers.
  • Existing methods have limitations in directly addressing diseased neural connectivity.
  • A novel approach is needed to accurately predict MS disease progression.

Purpose of the Study:

  • To propose an alternative method for predicting multiple sclerosis (MS) disease progression.
  • To leverage computational models and connectomes for enhanced disease trajectory prediction.
  • To explore the potential of the Hodgkin-Huxley model in simulating MS-related neural changes.

Main Methods:

  • Categorized existing MS prediction methods into clinical, radiological, biological, and computational markers.
  • Proposed using computational models combined with connectomes as a predictive tool.
  • Employed the Hodgkin-Huxley (HH) model to simulate signal propagation in a network, altering conduction parameters to mimic MS-related myelin changes.

Main Results:

  • The Hodgkin-Huxley model was validated for signal propagation dynamics under varying parameters.
  • Simulations demonstrated that altering conduction parameters in the network mimicked MS conditions.
  • Observed variations in signal propagation patterns provided insights into potential disease progression.

Conclusions:

  • Computational models, particularly the Hodgkin-Huxley model, offer a promising approach for predicting MS disease progression.
  • Integrating these models with connectomes can provide a deeper understanding of MS-related neural alterations.
  • This preliminary work opens a new avenue for developing advanced clinical tools for MS management.